H&M and Syre focus on Vietnam - Innovation in Textiles
6 hours ago • Google News
Spyre Therapeutics Inc. (SYRE)
US$ 14.13-5.36%
Price Chart
Key Statistics
Market Cap
$ 1.04B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
381.16K
52W High
$ 40.26
52W Low
$ 10.91
Dividend Yield
0.00%
Beta
2.73
Technicals
50-Day MA
14.7062
200-Day MA
22.8218
52 Week High
40.26
52 Week Low
10.91
About SYRE
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).
Employees
73
Headquarters
Waltham, MA
CEO
Dr. Cameron Turtle DPHIL, Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg